HIV/AIDS Update - Tentaive approval of generic nevirapine tablets, 200 mg

March 31, 2009--On March 31, 2009, the FDA granted tentative approval for a generic formulation of nevirapine tablets, USP, 200 mg indicated for combination antiretroviral treatment of HIV-1 infection.
The details can be read here.